Acorda Therapeutics, Inc. Derivative Liability, Noncurrent
Acorda Therapeutics, Inc. had Derivative Liability, Noncurrent of $0 as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2023-05-11
- 2023-03-31: Derivative Liability, Noncurrent $0.00.
- 2022-12-31: Derivative Liability, Noncurrent $0.00.
- 2022-03-31: Derivative Liability, Noncurrent $7.00K.
- 2021-12-31: Derivative Liability, Noncurrent $37.00K.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 |
| 2022-12-31 | $0.00 10-Q · filed 2023-05-11 |
| 2022-03-31 | $7.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $37.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | $325.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $613.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.42M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.19M 10-K · filed 2022-03-18 |
| 2020-09-30 | $832.00K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $23.95M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $32.88M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $59.41M 10-K · filed 2021-03-16 |